rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
1993-4-30
|
pubmed:abstractText |
Saccharomyces boulardii is a nonpathogenic yeast used for the prevention and treatment of Clostridium difficile-associated diarrhea and colitis. However, the mechanism by which S. boulardii exerts its protective effects remains unclear.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0016-5085
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
104
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1108-15
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:8462799-Animals,
pubmed-meshheading:8462799-Bacterial Toxins,
pubmed-meshheading:8462799-Chromatography, Affinity,
pubmed-meshheading:8462799-Clostridium difficile,
pubmed-meshheading:8462799-Electrophoresis, Polyacrylamide Gel,
pubmed-meshheading:8462799-Enterotoxins,
pubmed-meshheading:8462799-Ileum,
pubmed-meshheading:8462799-Male,
pubmed-meshheading:8462799-Mannitol,
pubmed-meshheading:8462799-Membrane Proteins,
pubmed-meshheading:8462799-Microvilli,
pubmed-meshheading:8462799-Molecular Weight,
pubmed-meshheading:8462799-Rabbits,
pubmed-meshheading:8462799-Rats,
pubmed-meshheading:8462799-Rats, Wistar,
pubmed-meshheading:8462799-Receptors, Immunologic,
pubmed-meshheading:8462799-Saccharomyces,
pubmed-meshheading:8462799-Tritium
|
pubmed:year |
1993
|
pubmed:articleTitle |
Saccharomyces boulardii inhibits Clostridium difficile toxin A binding and enterotoxicity in rat ileum.
|
pubmed:affiliation |
Evans Memorial Department of Clinical Research, University Hospital, Boston University School of Medicine, Massachusetts.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|